At Cook Children's, we believe that all children deserve the best treatment strategies available to manage their illness and maintain good health. Our research environment applies leading-edge scientific knowledge, technology and evidence-based practice to improve quality care outcomes for children.
See our latest research report
Research projects in the spotlight
Cook Children's has several departments that participate in clinical research studies.
Investigational drug services (IDS)
Coordinating all pharmacy processes and procedures for clinical research trials.
Find general information on clinical research studies as well as by specialty.
Cook Children's research in the news
Put to the Test
How a clinical trial in Fort Worth could lead the FDA to approve medical marijuana for patients who desperately need the drug: children with debilitating epilepsy. View article.
Aiming for the Moon
As an active research facility, Cook Children's Hematology and Oncology Center is currently participating in clinical trials aimed at stomping out childhood cancer and blood disorders. View article.
Training the Next Generation
Students from the Texas College of Osteopathic Medicine at UNT Health Science Center and Texas A&M spent time developing and conducting research with 15 providers serving as mentors. View report.
Cook Children's Institutional Review Board (IRB)
All studies done at Cook Children's must be reviewed and approved By Cook Children's Institutional Review Board (IRB) before the study begins, and at least annually for the duration of the study. The IRB is made up of community members, physicians, scientists, clergy and others. The IRB's role is to make sure each research study has safeguards in place and that study participants' rights are protected. The IRB also evaluates risk to participants to determine if they are reasonable when compared to the potential benefits.
For more information on research studies and programs at Cook Children's, please contact us at CookChildrensResearch@cookchildrens.org or 682-885-2103.